Spanning the 6 month time frame from November 2017 to May 2018, the S&P 500 (SPY) has increased ~+2.7%.
Within that time frame, SPDR S&P Biotech ETF (XBI) has also gone up ~+5.3%. So I find it interesting that once again these smaller biotech and biopharma stocks should be a nice addition to some portfolio's. The fact of the matter is that if you're trading biotech, you like speculation and can handle the risk...nothing more speculative than a low market cap, early stage company in this sector, and I, for one am all for the volatility that comes with it.
Article Link: https://medium.com/stock-market-source/5-biotech-stocks-with-breakthrough-treatments-a8397d5d0f5f
Submitted May 14, 2018 at 07:03AM by Ryan_Bentsen https://ift.tt/2IfknZ8
No comments:
Post a Comment